DMAC vs DTE
DiaMedica Therapeutics Inc (DMAC) versus DTE (DTE) — a side-by-side from cached financials, not a winner call.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
DTE (DTE) common stock.
DMAC does not have a complete income-statement cache yet.
DTE does not have a complete income-statement cache yet.
DMAC currently screens at market cap $157.4M. DTE currently screens at market cap $0.
Not investment advice. Open the DMAC and DTE stock pages for the full models.
Not investment advice.